- Home
- SENS vs PMI Comparison
SENS vs PMI Comparison
Compare SENS & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SENS | PMI |
|---|---|---|
| Founded | 1996 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 225.5M | 202.7M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | SENS | PMI |
|---|---|---|
| Price | $7.81 | $1.62 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $25.58 | N/A |
| AVG Volume (30 Days) | ★ 495.3K | 228.1K |
| Earning Date | 03-02-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $29,298,000.00 | $4,767,000.00 |
| Revenue This Year | $59.55 | N/A |
| Revenue Next Year | $70.49 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 31.94 | 8.81 |
| 52 Week Low | $5.25 | $1.61 |
| 52 Week High | $28.00 | $13.68 |
Technical Indicators
Market Signals| Indicator | SENS | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 74.48 | N/A |
| Support Level | $6.86 | N/A |
| Resistance Level | $7.30 | N/A |
| Average True Range (ATR) | 0.44 | 0.00 |
| MACD | 0.15 | 0.00 |
| Stochastic Oscillator | 93.96 | 0.00 |
Price Performance
Historical ComparisonAbout SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
About PMI Picard Medical Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.